Stanford Medicine Center for Cancer Cell Therapy

The Stanford Center for Cancer Cell Therapy is a world-class research program that is delivering life saving therapies to adult and pediatric cancer patients

Our impact has been most significant for B-Cell lymphoma malignancies, where CAR T cell therapy has become an FDA approved standard of care. We are now expanding in cell therapies for melanoma, advanced solid tumors, inoperable gliomas of the spine and brainstem, and refractory lymphoma.

Our ultimate goal is to drive the high-risk, high-reward research that fuels the development of groundbreaking cell therapies for patients with currently incurable cancers.

News & Research